Novel organosilicon compounds and anti-tumor agents containing the same
US4328216A · kind A · utility
8Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1979 |
| Grant date | May 4, 1982 |
| Priority date | — |
| Expiry date | Dec 10, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides a novel anti-tumor agent highly effective for inhibiting growth of several tumor or cancer cells with low toxicity. The active ingredient contained in the anti-tumor agent is an .omega.-triorganosilyl-substituted linear alkanoic acid anilide which is a hitherto unknown novel compound prepared by the reaction of corresponding acid chloride and aniline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.